Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Industry News
Share your love
Study establishes reference data set for geographic atrophy lesion progression
(Image Credit: AdobeStock/tadamichi) The lesion characteristics of patients with geographic atrophy (GA) were found to affect the lesion growth rate, with fovea-sparing, multifocal, and bilateral lesions having the fastest growth rates in a study published in Translational Vision Science &…
Oluwatosin U. Smith, MD, previews a program of collaborative care and practical learning
Educational committee member Oluwatosin U. Smith, MD, highlights the 2025 Ophthalmology Times EyeCon® and Optometry Times EyeCon® conference, a multispecialty meeting for ophthalmologists and optometrists, highlighting program updates, collaborative learning opportunities, and evolving approaches in patient care. To learn more…
RemeGen and Santen Enter into Exclusive Licensing Agreement for Ophthalmic Innovative Drug RC28-E in Greater China and Asian countries – PR Newswire
RemeGen and Santen Enter into Exclusive Licensing Agreement for Ophthalmic Innovative Drug RC28-E in Greater China and Asian countries PR Newswire Source: Author: | Date: 2025-08-18 07:00:00 Source: Author: | Date: 2025-08-18 07:00:00
Kiora CEO to Reveal Latest Retinal Disease Therapeutic Developments at Major Ophthalmology Conference – Stock Titan
Kiora CEO to Reveal Latest Retinal Disease Therapeutic Developments at Major Ophthalmology Conference Stock Titan Source: Author: | Date: 2025-08-07 07:00:00 Source: Author: | Date: 2025-08-07 07:00:00
Racial and ethnic diversity in ophthalmology: a meta-analysis of industry-sponsored phase 3 clinical trials from a single company – Nature
Racial and ethnic diversity in ophthalmology: a meta-analysis of industry-sponsored phase 3 clinical trials from a single company Nature Source: Author: | Date: 2025-06-12 07:00:00 Source: Author: | Date: 2025-06-12 07:00:00
FDA Green Lights Amneal's $201M Generic Eye Drug: Q3 2025 Launch Set for Pred Forte Alternative – Stock Titan
FDA Green Lights Amneal’s $201M Generic Eye Drug: Q3 2025 Launch Set for Pred Forte Alternative Stock Titan Source: Author: | Date: 2025-06-12 07:00:00 Source: Author: | Date: 2025-06-12 07:00:00
MD Student Presents at American Academy of Ophthalmology Conference – Elson S. Floyd College of Medicine
MD Student Presents at American Academy of Ophthalmology Conference Elson S. Floyd College of Medicine Source: Author: | Date: 2024-10-28 07:00:00 Source: Author: | Date: 2024-10-28 07:00:00
Debate Over The Future of Cataract Surgery
Cataract surgery has come a long way since its invention over 2,000 years ago. With the advancements in technology, the question on everyone’s mind is whether robots will take over the industry and perform all cataract surgeries. In order to…
Eye Drops Recall: Bacterial Infection Can Be Contagious
*This news has been updated, please click the link to see the updated version. The Centers for Disease Control and Prevention (CDC) have expressed concerns that a drug-resistant bacterial strain, linked to imported eyedrops from India, has spread from person…
The Effect of Psilocybin on Color Blindness
Researchers at the Department of Psychiatry and Psychology, Center for Behavioral Health, Neurological Institute at the Cleveland Clinic in Ohio have authored a case report on the potential positive effects of psilocybin on color blindness. The report, published in the…